[Irish Medical Times] , Gantly, Dara Four Irish sites participate in Hep C trial. (15 May 2014)
External website: http://www.imt.ie/news/uncategorized/2014/05/four-...
Four of Ireland’s major academic teaching hospitals have participated in a trial on a new hepatitis C drug regime that promises to revolutionise the future treatment of the disease.
Results of the pivotal phase III study, SAPPHIRE-II, were presented at the International Liver Congress (ILC) 2014 in London last month, together with detailed results from its phase III pivotal study, SAPPHIRE-I — both of which were published last month in The New England Journal of Medicine.
Repository Staff Only: item control page